American Riviera reports smaller net income, adds hundreds of new depositors
American Riviera Bank, based in Santa Barbara, reported a net income of $3 million for the quarter ending on March 31, representing a decrease of 6% over the same period last year. Earnings per share for the first quarter totaled 52 cents per share, compared with 55 cents per share this time last year, according Read More →
Amgen’s revenue dips in the first quarter, still beats earnings estimates
Thousand Oaks-based Amgen delivered a sound earnings beat in the first quarter of 2023, the company announced after the markets closed on April 27. Amgen, one of the largest biotechnology companies in the world, generated net income worth $2.8 billion in the first quarter or $5.28 earnings per share. This nearly doubled last year’s first-quarter Read More →
Teledyne starts the new year strong with earnings beat
Thousand Oaks-based Teledyne Technologies kicked off the earnings season right here on the Central Coast, delivering an earnings and revenue beat for the first quarter of 2023, the company announced on April 26 before the markets opened. Teledyne, a technology and defense conglomerate, delivered record revenue results in the first quarter, generating $1.38 billion in Read More →
Avocado pricing hurts Calavo’s first quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment revenue exceeds expectations in the third quarter
AeroVironment, headquartered in Virginia but still maintains operations in Simi Valley and Moorpark, saw a huge bump in revenue when the company released its earnings results for the third quarter after the markets closed March 6. A maker of drones, AeroVironment reported revenue worth $134.4 million for the quarter ended Dec. 31, an increase of Read More →
MannKind delivers record revenue
MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, delivered a record year for revenue behind its multiple products out in the market. Based in Westlake Village, MannKind generated revenue worth $99.7 million in 2022, up from $75.2 million in 2021. In the fourth quarter, revenue also shot up to $36 Read More →
Arcutis gearing up for active 2023
Arcutis Biotherapeutics generated sales from its first treatment during the fourth quarter of 2022, helping usher in a new era for the company. Based in Westlake Village, Arcutis recognized $3 million in revenue for the quarter that ended Dec. 31, all of it coming from its Zoryve cream aimed to treat plaque psoriasis. For the Read More →
